Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer

Autor: Janku, F., Johnson, L.K., Karp, D.D., Atkins, J.T., Singleton, P.A., Moss, J. *
Zdroj: In Annals of Oncology November 2016 27(11):2032-2038
Databáze: ScienceDirect